Galenica Ltd. develops, manufactures, and distributes pharmaceutical products in Switzerland and internationally. It operates in three segments: Vifor Pharma, Health & Beauty, and Services. The company offers iron replacement products, including Ferinject/Injectafer, Venofer, Maltofer, and Velphoro; immuno-stimulant products, such as Broncho-Vaxom and Uro-Vaxom; and synthetic and biotech drugs for use in immunology, as well as the treatment of infectious diseases. It also markets products manufactured by third parties; provides products for patients suffering from chronic kidney disease; and holds rights to develop and market CellCept for various applications involving auto-immune diseases. In addition, the company launches and distributes pharmaceutical and parapharmaceutical products, and offers marketing and sales services; and offers pre-wholesale logistics services, including storage and distribution of products, and debt collection services to pharmaceutical and healthcare companies. Further, it operates approximately 318 own pharmacies comprising 146 Amavita pharmacies, 102 Sun Store pharmacies, and 64 Vitality pharmacies, as well as 4 majority interests and 2 minority interests in pharmacies; and 173 partner pharmacies that include 12 Amavita and 161 Winconcept partner pharmacies. Additionally, the company provides master data systems for the healthcare market; publishes printed and electronic technical information on pharmaceutical products; and offers management solutions for pharmacies and physicians. Galenica Ltd. was founded in 1927 and is headquartered in Bern, Switzerland.
(GALN:SIX SWISS EXCHANGE AG)
Phone: 41 58 852 81 11
Fax: 41 58 852 81 12www.galenica.com
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for GALN.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact GALENICA AG-REG, please visit www.galenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.